van Lint, Jette A. http://orcid.org/0000-0003-2303-6199
Sonnenberg, Marlieke
Vonkeman, Harald E.
van den Bemt, Bart J. F.
van Puijenbroek, Eugene P.
Jessurun, Naomi T.
Funding for this research was provided by:
ZonMw (848050005)
Article History
Accepted: 2 August 2023
First Online: 31 August 2023
Declarations
:
: No funding was received for this specific study. The Dutch Biologic Monitor work was supported by the Netherlands Organisation for Health Research and Development (ZonMw) [Grant number 848050005].
: Jette A. van Lint, Marlieke Sonnenberg, Naomi T. Jessurun and Eugene P. van Puijenbroek have no conflicts of interest that are directly relevant to the content of this article. Bart J.F. van den Bemt has received consulting fees from AbbVie and payment for lectures from Lilly, UCB and Galapagos, all outside the submitted work. Harald E. Vonkeman has received grants, consulting fees or honoraria from AbbVie, Boehringer Ingelheim, Novartis, Pfizer, UCB, Janssen and Galapagos, all outside the submitted work.
: Ethical approval for the Dutch Biologic Monitor (file number: NW2016-66) and for the DOAC questionnaire study (file number: NW2017-10) were waived for the Dutch Medical Research Involving Human Subjects Act (WMO) by the Medical Research Ethical Committee of Brabant, the Netherlands. The Dutch Biologic Monitor was approved by the medical ethics committees of the participating hospitals. Ethical approval by an ethics committee or institutional review board for spontaneous reporting is not applicable.
: All participants of the Dutch Biologic Monitor and the DOAC questionnaire study received information prior to participation and signed a digital informed consent form.
: Not applicable as the reported data are anonymous.
: The datasets generated and/or analysed during the current study are available from the corresponding author on reasonable request.
: Not applicable.
: All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by JvL, NJ and MS. The first draft of the manuscript was written by JvL and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.